{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:41:15Z","timestamp":1778791275045,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ferroptosis, is characterized by lipid peroxidation of fatty acids in the presence of iron ions, which leads to cell apoptosis. This leads to the disruption of metabolic pathways, ultimately resulting in liver dysfunction. Although ferroptosis is linked to nonalcoholic steatohepatitis (NASH), understanding the key ferroptosis-related genes (FRGs) involved in NASH remains incomplete. NASH may be targeted therapeutically by identifying the genes responsible for ferroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To identify ferroptosis-related genes and develop a ferroptosis-related signature (FeRS), 113 machine-learning algorithm combinations were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The FeRS constructed using the Generalized Linear Model Boosting algorithm and Gradient Boosting Machine algorithms exhibited the best prediction performance for NASH. Eight FRGs, with ZFP36 identified by the algorithms as the most crucial, were incorporated into in FeRS. ZFP36 is significantly enriched in various immune cell types and exhibits significant positive correlations with most immune signatures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ZFP36 is a key FRG involved in NASH pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-023-01988-9","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T01:01:44Z","timestamp":1705971704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis"],"prefix":"10.1186","volume":"23","author":[{"given":"Longfei","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenkang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"1988_CR1","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47\u201364.","journal-title":"J Hepatol."},{"key":"1988_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatol. 2020;71:1851\u201364.","journal-title":"Hepatol."},{"key":"1988_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med."},{"issue":"Suppl 1","key":"1988_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/liv.13301","volume":"37","author":"P Bedossa","year":"2017","unstructured":"Bedossa P. Pathology of non-alcoholic fatty liver disease. Liver Int. 2017;37(Suppl 1):85\u20139.","journal-title":"Liver Int."},{"key":"1988_CR5","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324.","journal-title":"Lancet."},{"key":"1988_CR6","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537\u201364.","journal-title":"Cell."},{"key":"1988_CR7","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080.","journal-title":"Nat Rev Dis Primers."},{"key":"1988_CR8","first-page":"65","volume":"169","author":"XJ Wang","year":"2018","unstructured":"Wang XJ, Malhi H. Nonalcoholic fatty liver disease. Ann Intern Med. 2018;169:65\u201380.","journal-title":"Ann Intern Med"},{"key":"1988_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1988_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, Li X, Ge C, Min J, Wang F. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29:467\u201380.","journal-title":"Cell Death Differ."},{"key":"1988_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23:40\u201355.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1988_CR12","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo RC. Machine learning in medicine. Circulation. 2015;132:1920\u201330.","journal-title":"Circulation."},{"key":"1988_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13148-020-00842-4","volume":"12","author":"S Rauschert","year":"2020","unstructured":"Rauschert S, Raubenheimer K, Melton PE, Huang RC. Machine learning and clinical epigenetics: a review of challenges for diagnosis and classification. Clin Epigenetics. 2020;12:51.","journal-title":"Clin Epigenetics."},{"key":"1988_CR14","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2023","unstructured":"Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51:D571\u2013d582.","journal-title":"Nucleic Acids Res."},{"key":"1988_CR15","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun."},{"key":"1988_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.","journal-title":"BMC Bioinform."},{"key":"1988_CR17","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60\u2013w64.","journal-title":"Nucleic Acids Res."},{"key":"1988_CR18","doi-asserted-by":"publisher","first-page":"914781","DOI":"10.3389\/fcell.2022.914781","volume":"10","author":"Y Duan","year":"2022","unstructured":"Duan Y, Ni S, Zhao K, Qian J, Hu X. Immune cell infiltration and the genes associated with ligamentum flavum hypertrophy: identification and validation. Front Cell Dev Biol. 2022;10:914781.","journal-title":"Front Cell Dev Biol."},{"key":"1988_CR19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nprot.2015.052","volume":"10","author":"J Xia","year":"2015","unstructured":"Xia J, Gill EE, Hancock RE. NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat Protoc. 2015;10:823\u201344.","journal-title":"Nat Protoc."},{"key":"1988_CR20","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Lemma RB, Turchi L, Blanc-Mathieu R, et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2022;50:D165\u2013d173.","journal-title":"Nucleic Acids Res."},{"key":"1988_CR21","doi-asserted-by":"publisher","first-page":"W154","DOI":"10.1093\/nar\/gkad431","volume":"51","author":"S Tastsoglou","year":"2023","unstructured":"Tastsoglou S, Skoufos G, Miliotis M, Karagkouni D, Koutsoukos I, Karavangeli A, et al. DIANA-miRPath v4.0: expanding target-based miRNA functional analysis in cell-type and tissue contexts. Nucleic Acids Res. 2023;51:W154\u2013w159.","journal-title":"Nucleic Acids Res."},{"key":"1988_CR22","doi-asserted-by":"publisher","first-page":"D1036","DOI":"10.1093\/nar\/gkv1165","volume":"44","author":"AH Wagner","year":"2016","unstructured":"Wagner AH, Coffman AC, Ainscough BJ, Spies NC, Skidmore ZL, Campbell KM, et al. DGIdb 2.0: mining clinically relevant drug-gene interactions. Nucleic Acids Res. 2016;44:D1036\u201344.","journal-title":"Nucleic Acids Res."},{"key":"1988_CR23","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res."},{"key":"1988_CR24","doi-asserted-by":"publisher","first-page":"e0189223","DOI":"10.1371\/journal.pone.0189223","volume":"12","author":"C Baciu","year":"2017","unstructured":"Baciu C, Pasini E, Angeli M, Schwenger K, Afrin J, Humar A, et al. Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis. PLoS One. 2017;12:e0189223.","journal-title":"PLoS One."},{"key":"1988_CR25","doi-asserted-by":"publisher","first-page":"1184280","DOI":"10.3389\/fendo.2023.1184280","volume":"14","author":"L He","year":"2023","unstructured":"He L, Wang J, Tao B, Zhu R, Li C, Ning B. Identification of ferroptosis-related genes in the progress of NASH. Front Endocrinol (Lausanne). 2023;14:1184280.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1988_CR26","doi-asserted-by":"publisher","first-page":"7561645","DOI":"10.1155\/2021\/7561645","volume":"2021","author":"ZY Jiang","year":"2021","unstructured":"Jiang ZY, Zhou Y, Zhou L, Li SW, Wang BM. Identification of key genes and immune infiltrate in nonalcoholic steatohepatitis: a Bioinformatic analysis. Biomed Res Int. 2021;2021:7561645.","journal-title":"Biomed Res Int."},{"key":"1988_CR27","first-page":"567","volume":"14","author":"MJ Liu","year":"2021","unstructured":"Liu MJ, Jin H, Chen YB, Yu JJ, Guo ZY, He SQ, et al. Screening of non-alcoholic steatohepatitis (NASH)-related datasets and identification of NASH-related genes. Int J Clin Exp Pathol. 2021;14:567\u201381.","journal-title":"Int J Clin Exp Pathol."},{"key":"1988_CR28","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.2147\/IJGM.S317785","volume":"14","author":"M Ma","year":"2021","unstructured":"Ma M, Xie W, Li X. Identification of autophagy-related genes in the progression from non-alcoholic fatty liver to non-alcoholic steatohepatitis. Int J Gen Med. 2021;14:3163\u201376.","journal-title":"Int J Gen Med."},{"key":"1988_CR29","doi-asserted-by":"publisher","first-page":"872518","DOI":"10.3389\/fgene.2022.872518","volume":"13","author":"Q Meng","year":"2022","unstructured":"Meng Q, Li X, Xiong X. Identification of hub genes associated with non-alcoholic steatohepatitis using integrated bioinformatics analysis. Front Genet. 2022;13:872518.","journal-title":"Front Genet."},{"key":"1988_CR30","doi-asserted-by":"publisher","first-page":"862278","DOI":"10.3389\/fmed.2022.862278","volume":"9","author":"W Wang","year":"2022","unstructured":"Wang W, Liu X, Wei P, Ye F, Chen Y, Shi L, et al. SPP1 and CXCL9 promote non-alcoholic steatohepatitis progression based on bioinformatics analysis and experimental studies. Front Med (Lausanne). 2022;9:862278.","journal-title":"Front Med (Lausanne)."},{"key":"1988_CR31","doi-asserted-by":"publisher","first-page":"e54229","DOI":"10.15252\/embr.202154229","volume":"23","author":"S Yang","year":"2022","unstructured":"Yang S, Jia L, Xiang J, Yang G, Qiu S, Kang L, et al. KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7. EMBO Rep. 2022;23:e54229.","journal-title":"EMBO Rep."},{"key":"1988_CR32","doi-asserted-by":"publisher","first-page":"1115890","DOI":"10.3389\/fendo.2023.1115890","volume":"14","author":"JJ Zhang","year":"2023","unstructured":"Zhang JJ, Shen Y, Chen XY, Jiang ML, Yuan FH, Xie SL, et al. Integrative network-based analysis on multiple gene expression omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis. Front Endocrinol (Lausanne). 2023;14:1115890.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1988_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3350\/cmh.2022.0237","volume":"29","author":"KC Lee","year":"2023","unstructured":"Lee KC, Wu PS, Lin HC. Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. Clin Mol Hepatol. 2023;29:77\u201398.","journal-title":"Clin Mol Hepatol."},{"key":"1988_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15:349\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"1988_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","volume":"7","author":"J Wu","year":"2021","unstructured":"Wu J, Wang Y, Jiang R, Xue R, Yin X, Wu M, et al. Ferroptosis in liver disease: new insights into disease mechanisms. Cell Death Discov. 2021;7:276.","journal-title":"Cell Death Discov."},{"key":"1988_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki S, Tsuchiya Y, Koumura T, Nakasone M, Sakamoto T, Matsuoka M, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10:449.","journal-title":"Cell Death Dis."},{"key":"1988_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism."},{"key":"1988_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","volume":"15","author":"BA Neuschwander-Tetri","year":"2017","unstructured":"Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017;15:45.","journal-title":"BMC Med."},{"key":"1988_CR39","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev. 2019;40:1367\u201393.","journal-title":"Endocr Rev."},{"key":"1988_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12916-023-02818-6","volume":"21","author":"P Wu","year":"2023","unstructured":"Wu P, Wang Y, Ye Y, Yang X, Huang Y, Ye Y, et al. Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women. BMC Med. 2023;21:150.","journal-title":"BMC Med."},{"key":"1988_CR41","doi-asserted-by":"publisher","first-page":"7309","DOI":"10.1017\/S0033291723000867","volume":"53","author":"D Chen","year":"2023","unstructured":"Chen D, Zhang Y, Huang T, Jia J. Depression and risk of gastrointestinal disorders: a comprehensive two-sample Mendelian randomization study of European ancestry. Psychol Med. 2023;53:7309\u201321.","journal-title":"Psychol Med"},{"key":"1988_CR42","first-page":"e27203","volume":"2","author":"D Xu","year":"2013","unstructured":"Xu D, Yin C, Wang S, Xiao Y. JAK-STAT in lipid metabolism of adipocytes. Jakstat. 2013;2:e27203.","journal-title":"Jakstat."},{"key":"1988_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fonc.2020.00107","volume":"10","author":"X Fu","year":"2020","unstructured":"Fu X, Qie J, Fu Q, Chen J, Jin Y, Ding Z. miR-20a-5p\/TGFBR2 Axis affects pro-inflammatory macrophages and aggravates liver fibrosis. Front Oncol. 2020;10:107.","journal-title":"Front Oncol."},{"key":"1988_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrg3207","volume":"13","author":"F Spitz","year":"2012","unstructured":"Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet. 2012;13:613\u201326.","journal-title":"Nat Rev Genet."},{"key":"1988_CR45","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451\u201365.","journal-title":"J Cell Physiol."},{"key":"1988_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351\u201379.","journal-title":"Annu Rev Biochem."},{"key":"1988_CR47","doi-asserted-by":"publisher","first-page":"e105192","DOI":"10.1371\/journal.pone.0105192","volume":"9","author":"Y Tan","year":"2014","unstructured":"Tan Y, Ge G, Pan T, Wen D, Gan J. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS One. 2014;9:e105192.","journal-title":"PLoS One."},{"key":"1988_CR48","first-page":"1919","volume":"17","author":"TZ Wang","year":"2019","unstructured":"Wang TZ, Lin DD, Jin BX, Sun XY, Li N. Plasma microRNA: a novel non-invasive biomarker for HBV-associated liver fibrosis staging. Exp Ther Med. 2019;17:1919\u201329.","journal-title":"Exp Ther Med."},{"key":"1988_CR49","doi-asserted-by":"publisher","first-page":"40830","DOI":"10.18632\/oncotarget.8518","volume":"7","author":"C Shi","year":"2016","unstructured":"Shi C, Huang F, Gu X, Zhang M, Wen J, Wang X, et al. Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity. Oncotarget. 2016;7:40830\u201345.","journal-title":"Oncotarget."},{"key":"1988_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7150\/ijbs.80200","volume":"19","author":"RZ Tan","year":"2023","unstructured":"Tan RZ, Li JC, Zhu BW, Huang XR, Wang HL, Jia J, et al. Neuropeptide Y protects kidney from acute kidney injury by inactivating M1 macrophages via the Y1R-NF-\u03baB-Mincle-dependent mechanism. Int J Biol Sci. 2023;19:521\u201336.","journal-title":"Int J Biol Sci."}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01988-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T02:09:00Z","timestamp":1705975740000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01988-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1988"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01988-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3373283\/v1","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not only did all participants sign an informed consent form before participation, but the study was approved by the Ethics Committee of the First Affiliated Hospital of Anhui Medical University (approval number: 2023497).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}